Wistar Researchers Discover Possible New Treatment for
PHILADELPHIA, PA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the...
Stay updated with breaking news from Metabolomic Facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHILADELPHIA, PA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the...
Zachary Schug, Ph.D., assistant professor at The Wistar Institute, has published a new paper in the journal Nature Cancer demonstrates a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. Schug’s research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.
The Department of Science and Technology (DOST) announced Thursday, Aug. 26, that a new core facility at the Philippine Genome Center (PGC) is expected to be inaugurated next month. (PGC Facebook page) DOST Secretary Fortunato “Boy” T. de la Peña said the public can expect the inauguration of
E-Mail IMAGE: Wistar scientists characterized an inhibitor that targets acetate metabolism in cancer cells. This molecule caused tumor growth inhibition and regression in preclinical studies, demonstrating the promise of this approach as... view more Credit: The Wistar Institute PHILADELPHIA -- (Jan. 7, 2021) -- Scientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism in cancer cells. Cancer cells use acetate metabolism to support tumor growth in conditions of low nutrient and oxygen availability. This molecule caused tumor growth inhibition an...